AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2024

Mar 13, 2024

32106_dirs_2024-03-12_037943bd-dd46-466a-b1d5-b6d987f038f5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2024-03-08

Reporting Person: MOORE TIMOTHY L. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-03-08	Common Stock	A	11264	—	Acquired	29897	Direct

Footnotes

F1: The restricted stock was granted pursuant to the BioLife Solutions 2023 Performance Incentive Plan (the "2023 Plan") and fully vests on the first anniversary of the grant date.